Microbot Medical® Liberty®血管介入机器人系统获多地区采用涵盖两个ACCESS-PVI关键临床试验基地

美股速递05-05

Microbot Medical Inc旗下Liberty®血管介入机器人系统目前已在多个重点区域获得临床应用，其中包括两个参与ACCESS-PVI关键临床试验的医疗中心。该系统的推广部署标志着血管介入手术机器人技术迈向更广泛的临床验证阶段。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1124217129?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-05 20:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124217129","market":"us","top_or_hot":-1,"title":"Microbot Medical® Liberty®血管介入机器人系统获多地区采用 涵盖两个ACCESS-PVI关键临床试验基地","media":"美股速递","content":"<p>Microbot Medical Inc旗下Liberty®血管介入机器人系统目前已在多个重点区域获得临床应用，其中包括两个参与ACCESS-PVI关键临床试验的医疗中心。该系统的推广部署标志着血管介入手术机器人技术迈向更广泛的临床验证阶段。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microbot Medical® Liberty®血管介入机器人系统获多地区采用 涵盖两个ACCESS-PVI关键临床试验基地</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrobot Medical® Liberty®血管介入机器人系统获多地区采用 涵盖两个ACCESS-PVI关键临床试验基地\n</h2>\n\n<h4 class=\"meta\">\n\n2026-05-05 20:31 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Microbot Medical Inc旗下Liberty®血管介入机器人系统目前已在多个重点区域获得临床应用，其中包括两个参与ACCESS-PVI关键临床试验的医疗中心。该系统的推广部署标志着血管介入手术机器人技术迈向更广泛的临床验证阶段。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MBOT","symbol_name":"Microbot Medical Inc","start_time":0,"source_url":"","article_id":"1124217129","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124217129","pubTimestamp":1777984282,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Microbot Medical Inc旗下Liberty®血管介入机器人系统目前已在多个重点区域获得临床应用，其中包括两个参与ACCESS-PVI关键临床试验的医疗中心。该系统的推广部署标志着血管介入手术机器人技术迈向更广泛的临床验证阶段。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MBOT":"Microbot Medical Inc","BK4082":"医疗保健设备"},"translate_title":"Microbot Medical ® Liberty ® Vascular Interventional Robotics System Receives Multi-Regional Adoption, Covering Two Key ACCESS-PVI Clinical Trial Bases","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MBOT":1},"content_text":"Microbot Medical Inc旗下Liberty®血管介入机器人系统目前已在多个重点区域获得临床应用，其中包括两个参与ACCESS-PVI关键临床试验的医疗中心。该系统的推广部署标志着血管介入手术机器人技术迈向更广泛的临床验证阶段。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124217129","isCrawlerRequest":true}

Microbot Medical® Liberty®血管介入机器人系统获多地区采用 涵盖两个ACCESS-PVI关键临床试验基地

精彩评论

Microbot Medical® Liberty®血管介入机器人系统获多地区采用涵盖两个ACCESS-PVI关键临床试验基地